UNSPSC 85815026: Introduction of other anti-infective into products of conception, via natural or artificial opening

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of other anti-infective into products of conception, via natural or artificial opening. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0E729

UNSPSC 85815026 Introduction of other anti-infective into products of conception, via natural or artificial opening is a Commodity code that does not align with identifiable state and local government procurement activity. The recent opportunities tagged under this code reflect substantive mismatches with the nominal code scope—a medical/obstetric procedure code—and instead capture healthcare services, behavioral health programs, staffing, and equipment procurement wholly unrelated to the procedural intervention the code describes.

The source records show no recent state and local solicitations actually seeking the service or product named in the code itself. Instead, the tagged opportunities span Inland Empire Health Plan (California) requesting virtual urgent care services via RFI; DeKalb County (Georgia) requesting medical services proposals; Nevada Health Authority requesting PACE operations and rural value-based care facilitation; San Mateo County (California) requesting cancer registry services and retinal screening devices; Boulder County (Colorado) requesting EMT staffing; City of Ocala (Florida) requesting employee health clinic management; and a fragmented set of additional jurisdictions soliciting occupational health screenings, EMS billing, nursing home placement beds, wellness platforms, psychological evaluations, travel nurse staffing, disability medical evaluations, and opioid use disorder treatment services across California, Colorado, Florida, Georgia, Kansas, Missouri, Nevada, Oregon, Texas, and the District of Columbia. None of these opportunities involves introducing anti-infective agents into products of conception. The code appears to have been assigned erroneously to a broad set of health service procurements, or the taxonomy itself does not reflect current state and local health procurement practice. For business development purposes, this code shows no actionable procurement signal and should not be pursued based on the recent-opportunities record.